Swati Abbott - Magellan Health Director

Director

Ms. Swati Abbott is Independent Director of the Company. She currently serves as the president and chief executive officer of Health Intelligence Company LLC, doing business as Blue Health Intelligence, a healthcare data and analytics company, a post that she has held since 2011. Prior to joining Blue Health Intelligence, Ms. Abbott served as the president of MEDai, Inc., an industry leader in predictive analytics which was acquired by Reed Elsevier in 2008. She also served as managing director for the Medical Management Strategic Business Unit at ViPS. Ms. Abbott was nominated for the first time for election as a director in 2018 due to her knowledge and experience in healthcare data analytics and managed care generally. since 2018.
Age 53
Tenure 6 years
Phone800 642-1716
Webwww.magellanhealth.com

Magellan Health Management Efficiency

The company has return on total asset (ROA) of 0.54 % which means that it generated a profit of $0.54 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.16) %, meaning that it created substantial loss on money invested by shareholders. Magellan Health's management efficiency ratios could be used to measure how well Magellan Health manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 562.64 M in liabilities with Debt to Equity (D/E) ratio of 0.28, which may suggest the company is not taking enough advantage from borrowing. Magellan Health has a current ratio of 2.86, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Magellan Health until it has trouble settling it off, either with new capital or with free cash flow. So, Magellan Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Magellan Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Magellan to invest in growth at high rates of return. When we think about Magellan Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Erin NelsonSkyline
50
John FirthSkyline
60
Lance FritzParker Hannifin
57
William FuerstPaul Mueller Co
N/A
Carolyn CorviUnited Airlines Holdings
66
Robert MiltonUnited Airlines Holdings
55
Robert KohlheppParker Hannifin
72
William LaceyParker Hannifin
55
Todd InslerUnited Airlines Holdings
49
Patrick HanleyOld Dominion Freight
73
Jane GarveyUnited Airlines Holdings
74
James HlavacekPaul Mueller Co
N/A
Barbara AllenDR Horton
74
James KennedyUnited Airlines Holdings
64
David SmithSkyline
N/A
Laurence SimmonsUnited Airlines Holdings
69
Jillian EvankoParker Hannifin
42
Jerry HammesSkyline
84
John KasardaOld Dominion Freight
72
Walter IsaacsonUnited Airlines Holdings
65
James WainscottParker Hannifin
63
Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation. Magellan Health operates under Healthcare Plans classification in the United States and is traded on NASDAQ Exchange. It employs 9000 people. Magellan Health (MGLN) is traded on NASDAQ Exchange in USA and employs 9,000 people.

Management Performance

Magellan Health Leadership Team

Elected by the shareholders, the Magellan Health's board of directors comprises two types of representatives: Magellan Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Magellan. The board's role is to monitor Magellan Health's management team and ensure that shareholders' interests are well served. Magellan Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Magellan Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Eran Broshy, Independent Director
Swati Abbott, Director
Mostafa Kamal, Senior Vice President and General Manager
Scott MacKenzie, Independent Director
Barry Smith, Chairman and CEO
Mary Sammons, Independent Director
Joe Bogdan, Senior Vice President Corporate Finance
Steven Shulman, Independent Director
Matthew Simas, Director
Perry Fine, Independent Director
Daniel Gregoire, General Counsel and Secretary
Kay James, Director
Srinivas Koushik, CTO
Leslie Norwalk, Independent Director
John Agwunobi, Independent Director
John Littel, Senior Vice President - Government Affairs and Communications
Michael Diament, Independent Director
William McBride, Independent Director
Guy Sansone, Independent Director
Peter Feld, Independent Director
Renie Shapiro, Senior Vice President Corporate Finance
Michael Ressner, Independent Director
Sanjeev Srivastava, CEO of Magellan Healthcare
Caskie LewisClapper, Chief Human Resource Officer

Magellan Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Magellan Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Consideration for investing in Magellan Stock

If you are still planning to invest in Magellan Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Magellan Health's history and understand the potential risks before investing.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine